CT based surveillance programme following resection of early stage lung cancer | Lung Cancer Nursing UK Skip to main content

CT based surveillance programme following resection of early stage lung cancer

By Jenny Mitchell, Oxford University Hospital

Category: Follow-Up and End-of-Life Care

The problem identified

The ideal follow-up for resected lung cancer patients remains uncertain. CXR follow-up protocols have been standard practice after thoracic surgery but are of limited benefit in picking up small abnormalities in the chest, distant disease will also be missed. CT follow-up offers improved imaging but with increased exposure to radiation and an increased workload for the Radiology department.

The intervention made to change the problem

Following discussion within the MDT we introduced standardised follow-up protocols for patients following thoracic surgery. Our initial protocol was for 6 monthly follow-up for 2 years with CT chest, abdomen and pelvis with contrast at 6 months and 18 months, then annual follow-up to 5 years postoperatively with a further CT chest abdomen and pelvis with contrast at 4 years.
Following review of the first 3 years of results this has now been amended, the timing of follow-up remains the same but a CT chest, abdomen and pelvis with contrast is performed prior to every appointment.

How it changed my practice

The CT follow-up programme is now embedded in our MDT practice. All patient who have primary lung cancer resected and do not require adjuvant treatment follow the protocol. Patients attend for a CT one month prior to their follow-up appointment, allowing time for the images to be reported before the patient is seen. Abnormal CT results are triaged by the nurse practitioner, repeat imaging is arranged if recommended by the reporting radiologist, all other abnormal results are discussed at the lung MDT.
In the first 3 years of the programme 28% of CTs were abnormal, half of these patients went on to be diagnosed with malignancy. The non-malignant abnormalities were most commonly nodules under continuing follow-up or infection related abnormalities. The programme has detected 79% of cancers prior to the development of clinical symptoms. 5% of patients under follow-up developed recurrent lung cancer, 3.5% had new lung primaries and 1% had non-lung primaries detected. 57% of the CT detected tumours were radically treated. 85% of the radically treated patients had their disease detected in the first 18 months after surgery, compared to 45% of the palliative treatment group.

Resource / Cost implications

Increased burden of work in the lung cancer MDT - abnormal results need to be discussed, not all of the abnormal results turn out to be recurrent/new cancers.
Increased number of CT image requests.

Published:

Join Lung Cancer Nursing UK

Be a member of a dynamic and cohesive forum of lung cancer nurse specialists (LCNS) working throughout the UK. Membership costs just £30 per year and is open to any specialist nurse who spends more than 50% of their working week or clinical activities in caring for patients with lung cancer.

Join Now

LCNUK Webinar Series

Our series of webinars will be continuing throughout 2022.

We hope you can join us on online.

Register for Upcoming Webinars